Want to join the conversation?
Medical products company $JNJ said its pharma unit Janssen Biologics BV received approval from the European Commission for SIMPONIÂ® for the treatment of polyarticular juvenile idiopathic arthritis. SIMPONI combined with methotrexate is approved for use in children who weigh at least 40 kg and who have failed previous treatment with MTX.
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.